Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.33 |
| ▸ | MPO | P05164 | 2/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL548121 | 0.82 | STAT3 (0.35) | — | |
| SCHEMBL5703319 | 0.82 | STAT3 (0.31) | — | |
| SCHEMBL10428620 | 0.80 | STAT3 (0.39) | — | |
| SCHEMBL549066 | 0.80 | STAT3 (0.39) | — | |
| SCHEMBL548131 | 0.80 | STAT3 (0.39) | — | |
| SCHEMBL6910095 | 0.80 | STAT3 (0.39) | — | |
| SCHEMBL586641 | 0.80 | STAT3 (0.39) | — | |
| SCHEMBL549041 | 0.80 | STAT3 (0.39) | — | |
| SCHEMBL10428730 | 0.80 | STAT3 (0.39) | — | |
| SCHEMBL4821000 | 0.79 | DAO (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008157824-A2 | THROMBOPOIETIN PEPTIDE CONJUGATES | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2008-12-24 | — | — | WO | claimed |
| EP-4313009-A1 | MAYTANSINE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | Angiex, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2023239803-A1 | ANTI-TM4SF1 ANTIBODY-DRUG CONJUGATES COMPRISING CLEAVABLE LINKERS AND METHODS OF USING SAME | ANGIEX, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| EP-4204013-A1 | ANTIMITOTIC TETRAPEPTIDE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | Angiex, Inc. (US) | 2023-07-05 | — | — | EP | disclosed |
| EP-4188449-A2 | ANTI-TM4SF1 ANTIBODY-DRUG CONJUGATES COMPRISING CLEAVABLE LINKERS AND METHODS OF USING SAME | Angiex, Inc. (US) | 2023-06-07 | — | — | EP | disclosed |
| WO-2022026915-A9 | ANTI-TM4SF1 ANTIBODY-DRUG CONJUGATES COMPRISING CLEAVABLE LINKERS AND METHODS OF USING SAME | ANGIEX, INC. (US) | 2022-04-28 | — | — | WO | disclosed |
| WO-2022046941-A1 | ANTIMITOTIC TETRAPEPTIDE-ANTIBODY CONJUGATES AND METHODS OF USING SAME | ANGIEX, INC. (US) | 2022-03-03 | — | — | WO | disclosed |
| WO-2022026915-A2 | ANTI-TM4SF1 ANTIBODY-DRUG CONJUGATES COMPRISING CLEAVABLE LINKERS AND METHODS OF USING SAME | ANGIEX, INC. (US) | 2022-02-03 | — | — | WO | disclosed |
| WO-2021222783-A1 | ANTI-TM4SF1 ANTIBODY DRUG CONJUGATES AND METHODS OF USING SAME | ANGIEX, INC. (US) | 2021-11-04 | — | — | WO | disclosed |
| EP-3625245-A1 | PEPTIDE COMPOUNDS, CONJUGATE COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATORY DISEASES | Transfert Plus, S.E.C. (CA) | 2020-03-25 | — | — | EP | disclosed |
| WO-2010142035-A1 | FUSION PROTEINS FOR DELIVERY OF GDNF AND BDNF TO THE CENTRAL NERVOUS SYSTEM | ANGIOCHEM INC. (CA) | 2010-12-16 | — | — | WO | disclosed |
| EP-2231191-A2 | FORMULATION OF INSULINOTROPIC PEPTIDE CONJUGATES | ConjuChem Biotechnologies Inc. (CA) | 2010-09-29 | — | — | EP | disclosed |
| WO-2010069074-A1 | MEMBRANE TYPE-1 MATRIX METALLOPROTEIN INHIBITORS AND USES THEREOF | UNIVERSITE DU QUEBEC A MONTREAL (CA) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010063124-A1 | PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010063123-A1 | LEPTIN AND LEPTIN ANALOG CONJUGATES AND USES THEREOF | ANGIOCHEM INC. (CA) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010063122-A1 | CONJUGATES OF NEUROTENSIN OR NEUROTENSIN ANALOGS AND USES THEREOF | ANGIOCHEM INC. (CA) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010043047-A1 | CONJUGATES OF GLP-1 AGONISTS AND USES THEREOF | ANGIOCHEM INC. (CA) | 2010-04-22 | — | — | WO | disclosed |
| EP-2114437-A2 | MODIFIED CORTICOTROPIN RELEASING FACTOR PEPTIDES AND USES THEREOF | ConjuChem Biotechnologies Inc. (CA) | 2009-11-11 | — | — | EP | disclosed |
| WO-2009075859-A2 | FORMULATION OF INSULINOTROPIC PEPTIDE CONJUGATES | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2009-06-18 | — | — | WO | disclosed |
| WO-2008047241-A2 | MODIFIED CORTICOTROPIN RELEASING FACTOR PEPTIDES AND USES THEREOF | CONJUCHEM BIOTECHNOLOGIES INC. (US) | 2008-04-24 | — | — | WO | disclosed |